• Molecular NameDesoxycorticosterone Pivalate
  • SynonymDeoxycorticosterone Pivalate; Deoxycorticosterone Trimethylacetate; Deoxycortolone Pivalate; Deoxycortone Pivalate; Deoxycortone Trimethylacetate; Desoxycorticosterone Trimethylacetate; Desoxycortone Pivalate; DOCP; DTMA
  • Weight414.586
  • Drugbank_IDDB01134
  • ACS_NO808-48-0
  • Show 3D model
  • LogP (experiment)5.544
  • LogP (predicted, AB/LogP v2.0)4.26
  • pkaN/A
  • LogD (pH=7, predicted)4.26
  • Solubility (experiment)Insoluble
  • LogS (predicted, ACD/Labs)(ph=7)-6.07
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.0
  • No.of HBond Donors0
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds5
  • TPSA60.44
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyDesoxycorticosterone Pivalate is a mineralocorticoid hormone and an analog of desoxycorticosterone.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding90.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySymptoms of overdose include polyuria, polydipsia, increased blood volume, edema, and cardiac enlargement.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A